Walz AL, Fernandez CV, Geller JI (2019) Novel therapy for pediatric and adolescent kidney cancer. Cancer Metastasis Rev 38:643–655. https://doi.org/10.1007/s10555-019-09822-4
Spreafico F, Fernandez CV, Brok J, Nakata K, Vujanic G, Geller JI, Gessler M, Maschietto M, Behjati S, Polanco A, Paintsil V, Luna-Fineman S, Pritchard-Jones K (2021) Wilms tumour. Nat Rev Dis Primers 7:75. https://doi.org/10.1038/s41572-021-00308-8
Pan C, Cai J-Y, Xu M, Ye Q-D, Zhou M, Yin M-Z, Zhong Y-M, Chen J, Shen S-H, Tang J-Y (2015) Renal tumor in developing countries: 142 cases from a single institution at Shanghai, China. World J Pediatr 11:326–330. https://doi.org/10.1007/s12519-015-0041-3
van den Heuvel-Eibrink MM, Hol JA, Pritchard-Jones K, van Tinteren H, Furtwangler R, Verschuur AC, Vujanic GM, Leuschner I, Brok J, Rube C, Smets AM, Janssens GO, Godzinski J, Ramirez-Villar GL, de Camargo B, Segers H, Collini P, Gessler M, Bergeron C, Spreafico F, Graf N (2017) Position paper: Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP-RTSG 2016 protocol. Nat Rev Urol 14:743–752. https://doi.org/10.1038/nrurol.2017.163. and International Society of Paediatric Oncology - Renal Tumour Study
Gratias EJ, Dome JS, Jennings LJ, Chi Y-Y, Tian J, Anderson J, Grundy P, Mullen EA, Geller JI, Fernandez CV, Perlman EJ (2016) Association of chromosome 1q Gain with Inferior Survival in favorable-histology Wilms Tumor: a Report from the children’s Oncology Group. J Clin Oncology: Official J Am Soc Clin Oncol 34:3189–3194. https://doi.org/10.1200/JCO.2015.66.1140
Park JE, Noh OK, Lee Y, Choi HS, Han JW, Hahn SM, Lyu CJ, Lee JW, Yoo KH, Koo HH, Jeong S-Y, Sung KW (2020) Loss of Heterozygosity at chromosome 16q is a negative prognostic factor in Korean Pediatric patients with favorable Histology Wilms Tumor: a report of the Korean Pediatric Hematology Oncology Group (K-PHOG). Cancer Res Treat 52:438–445. https://doi.org/10.4143/crt.2019.313
Sudour-Bonnange H, Dijoud F, Leclair M-D, Rocourt N, Bergeron C (2016) [Clear cell sarcoma of kidney in children]. Bull Cancer 103:402–411. https://doi.org/10.1016/j.bulcan.2016.01.017
Ueno-Yokohata H, Okita H, Nakasato K, Akimoto S, Hata J-i, Koshinaga T, Fukuzawa M, Kiyokawa N (2015) Consistent in-frame internal tandem duplications of BCOR characterize clear cell sarcoma of the kidney. Nat Genet 47:861–863. https://doi.org/10.1038/ng.3338
Article CAS PubMed Google Scholar
Schulpen M, Roy P, Wijnen MHWA, Tytgat GAM, van den Heuvel-Eibrink MM, van Tinteren H, Karim-Kos HE (2022) Incidence and survival of paediatric renal tumours in the Netherlands between 1990 and 2014. Eur J Cancer 175:282–290. https://doi.org/10.1016/j.ejca.2022.08.021
Dong X, Chen Y, Pan J, Ma W, Zhou P, Chen M, Guo H, Gan W (2022) Clinicopathological features and prognosis of TFE3-positive renal cell carcinoma. Front Oncol 12:1017425. https://doi.org/10.3389/fonc.2022.1017425
Article PubMed PubMed Central Google Scholar
Wegert J, Vokuhl C, Collord G, Del Castillo Velasco-Herrera M, Farndon SJ, Guzzo C, Jorgensen M, Anderson J, Slater O, Duncan C, Bausenwein S, Streitenberger H, Ziegler B, Furtwängler R, Graf N, Stratton MR, Campbell PJ, Jones DT, Koelsche C, Pfister SM, Mifsud W, Sebire N, Sparber-Sauer M, Koscielniak E, Rosenwald A, Gessler M, Behjati S (2018) Recurrent intragenic rearrangements of EGFR and BRAF in soft tissue tumors of infants. Nat Commun 9:2378. https://doi.org/10.1038/s41467-018-04650-6
Article CAS PubMed PubMed Central Google Scholar
Tang W, Liu Z, Fu H, Li C, Wang H (2019) FDG PET/CT evaluation of Pediatric patients with yolk sac tumor. AJR Am J Roentgenol 213:676–682. https://doi.org/10.2214/AJR.18.20968
Chen S, He K, Feng F, Wang S, Yin Y, Fu H, Wang H (2019) Metabolic tumor burden on baseline (18)F-FDG PET/CT improves risk stratification in pediatric patients with mature B-cell lymphoma. Eur J Nucl Med Mol Imaging 46:1830–1839. https://doi.org/10.1007/s00259-019-04363-y
Article CAS PubMed Google Scholar
Gopal S, Gross TG (2018) How I treat Burkitt lymphoma in children, adolescents, and young adults in sub-saharan Africa. Blood 132:254–263. https://doi.org/10.1182/blood-2018-04-844472
Article CAS PubMed PubMed Central Google Scholar
Hoppe BS, Hill-Kayser CE, Tseng YD, Flampouri S, Elmongy HM, Cahlon O, Mendenhall NP, Maity A, McGee LA, Plastaras JP (2017) Consolidative proton therapy after chemotherapy for patients with Hodgkin lymphoma. Ann Oncol 28:2179–2184. https://doi.org/10.1093/annonc/mdx287
Article CAS PubMed PubMed Central Google Scholar
Filizoglu N, Oksuzoglu K, Bozkurt S, Ozguven S, Erdil TY (2021) FDG PET/CT findings of Extrarenal Wilms Tumor originating from the spinal cord. Clin Nucl Med 46:86–87. https://doi.org/10.1097/RLU.0000000000003297
Provenzi M, Saettini F, Conter V, Chinaglia D, Vai P, Bruno A, Cavalleri L, Foglia C, Giraldi E, Collini P, Spreafico F (2013) Is there a role for FDG-PET for the assessment of treatment efficacy in Wilms’ tumor? A case report and literature review. Pediatr Hematol Oncol 30:633–639. https://doi.org/10.3109/08880018.2013.832446
Article CAS PubMed Google Scholar
Seifert RP, McNab P, Sexton WJ, Sawczyn KK, Smith P, Coppola D, Bui MM (2012) Rhabdomyomatous differentiation in Wilms tumor pulmonary metastases: a case report and literature review. Ann Clin Lab Sci 42:409–416
Green DM, Beckwith JB, Weeks DA, Moksness J, Breslow NE, D’Angio GJ (1994) The relationship between microsubstaging variables, age at diagnosis, and tumor weight of children with stage I/favorable histology Wilms’ tumor. A report from the National Wilms’ Tumor study. Cancer 74:1817–1820
Article CAS PubMed Google Scholar
Moinul Hossain AKM, Shulkin BL, Gelfand MJ, Bashir H, Daw NC, Sharp SE, Nadel HR, Dome JS (2010) FDG Positron emission tomography/computed tomography studies of Wilms’ tumor. Eur J Nucl Med Mol Imaging 37:1300–1308. https://doi.org/10.1007/s00259-010-1396-2
Article CAS PubMed PubMed Central Google Scholar
Misch D, Steffen IG, Schönberger S, Voelker T, Furth C, Stöver B, Hautzel H, Henze G, Amthauer H, Denecke T (2008) Use of positron emission tomography for staging, preoperative response assessment and posttherapeutic evaluation in children with Wilms tumour. Eur J Nucl Med Mol Imaging 35:1642–1650. https://doi.org/10.1007/s00259-008-0819-9
留言 (0)